Bruno V. V.
- Country
- Belgium
- Department
- Nephrology department
Research Overview
- Efficacy and Safety of Oral BI 764198 in Adults and Adolescents with Primary or TRPC6-Variant Genetic Focal Segmental Glomerulosclerosis: A Randomized, Placebo-Controlled Trial
- Phase II Basket Trial of BI 764198 in Adults and Adolescents With Proteinuric Kidney Diseases
- Efficacy and Safety Assessment of Finerenone and Empagliflozin Combination Versus Monotherapy in Chronic Kidney Disease with Type 2 Diabetes
Data & Insights
Has run more than one trial at 63 of 296 partner sites.
Specializations
Renal Medicine
This investigator specializes in treating chronic kidney disease (CKD), with particular focus on its relationship with type 2 diabetes mellitus and hypertension.
- Kidney Function Management
- Diabetic Nephropathy
- Hypertensive Kidney Disease
The investigator explores innovative therapeutic approaches in renal medicine, particularly focusing on urinary albumin-to-creatinine ratio management.
Cardiometabolic Health
The investigator has expertise in managing complex cardiometabolic conditions, particularly focusing on the intersection of cardiovascular health and renal function.
- Blood Pressure Management
- Cardiovascular Risk Reduction
- Metabolic Disease Management
Their work encompasses comprehensive approaches to treating patients with multiple comorbid conditions affecting cardiovascular and renal systems.
Therapeutic Innovation
The investigator evaluates novel therapeutic combinations for complex renal conditions, including combination therapy approaches for kidney disease management.
- Combined Treatment Strategies
- Renal Protection Therapies
- Progressive Disease Management
Their expertise extends to assessing therapeutic interventions that target multiple disease pathways simultaneously.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.